Innovative inhaler: the Novolizer
On the global market
The Novolizer is now on sale on the global market and the number of asthma and COPD drugs for which it can be used will soon be increased. Various pharmaceutical companies are involved in its further development. In addition, De Boer and Frijlink and their team of specialists are currently working on a special disposable inhaler (the Twincer) for administering drugs for conditions such as cystic fibrosis and tuberculosis. The pharmaceutical industry is already keenly anticipating this new inhaler, as it is also suitable for administering flu jabs and vaccinations against various other infectious diseases. It is thought that the Twincer will be available for use by patients in just a few years.
On 21 April 2010, Anne de Boer and Erik Frijlink were awarded the Wubbo Ockels prize for the successful development of this innovative Novolizer inhaler.
Last modified: | 22 May 2018 10.35 a.m. |
More news
-
25 June 2024
Heineken Young Scientists Award for Casper van der Kooi
For his research in the field of Natural Sciences, Casper van der Kooi will receive the Heineken Young Scientists Award.
-
24 June 2024
Measuring stickiness
Several plant species use tiny sticky droplets to attract and trap insects. These droplets form an ideal toxin-free insecticide that could be easily washed off of edible plants. Abinaya Arunachalam built a tool to measure the stickiness of...
-
20 June 2024
Kick-starting seagrass for a climate-proof sea
Seagrasses have all but disappeared throughout the world, but these unique saltwater plants play a vital role in an ecosystem. On the occasion of the World Seagrass Conference this week (17-21 June) in Naples, Italy, the BBC premieres a mini...